These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33394867)

  • 1. Limited reliability of heart rate as a sympathetic marker in chronic kidney disease.
    Dell'Oro R; Quarti-Trevano F; Seravalle G; Bertoli S; Lovati C; Mancia G; Grassi G
    J Hypertens; 2021 Jul; 39(7):1429-1434. PubMed ID: 33394867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
    Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
    J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease.
    Grassi G; Fowler B; Scali B; Rossi F; Motto E; Pieruzzi F; Mancia G
    J Hypertens; 2022 Aug; 40(8):1530-1536. PubMed ID: 35792492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate as a sympathetic marker during acute adrenergic challenge.
    Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
    J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome.
    Seravalle G; Vanoli J; Molisano C; Merati V; Grassi G
    Acta Diabetol; 2022 Nov; 59(11):1429-1435. PubMed ID: 35904642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated heart rate as sympathetic biomarker in human obesity.
    Seravalle G; Facchetti R; Cappellini C; Annaloro A; Gelfi E; Grassi G
    Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2367-2374. PubMed ID: 35970685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Facchetti R; Mancia G
    Hypertension; 2020 Aug; 76(2):577-582. PubMed ID: 32594806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis.
    Grassi G; Biffi A; Seravalle G; Bertoli S; Airoldi F; Corrao G; Pisano A; Mallamaci F; Mancia G; Zoccali C
    J Hypertens; 2021 Mar; 39(3):408-416. PubMed ID: 33031182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity.
    Grassi G; Seravalle G; Dell'Oro R; Arenare F; Facchetti R; Mancia G
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):469-75. PubMed ID: 19157817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure.
    Grassi G; Seravalle G; Vanoli J; Facchetti R; Spaziani D; Mancia G
    Clin Res Cardiol; 2023 Jan; 112(1):59-67. PubMed ID: 35552503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in sympathetic activity and pulse wave velocity in adults with chronic kidney disease.
    Zanuzzi MG; Jeong J; DaCosta DR; Park J
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F661-F668. PubMed ID: 38385174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction.
    Seravalle G; Quarti-Trevano F; Dell'Oro R; Gronda E; Spaziani D; Facchetti R; Cuspidi C; Mancia G; Grassi G
    J Hypertens; 2019 Feb; 37(2):443-448. PubMed ID: 30020242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies.
    Quarti Trevano F; Dell'Oro R; Biffi A; Seravalle G; Corrao G; Mancia G; Grassi G
    J Hypertens; 2020 Apr; 38(4):565-572. PubMed ID: 32132429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension.
    Grassi G; Seravalle G; Brambilla G; Pini C; Alimento M; Facchetti R; Spaziani D; Cuspidi C; Mancia G
    Int J Cardiol; 2014 Dec; 177(3):1020-5. PubMed ID: 25449517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early sympathetic activation in the initial clinical stages of chronic renal failure.
    Grassi G; Quarti-Trevano F; Seravalle G; Arenare F; Volpe M; Furiani S; Dell'Oro R; Mancia G
    Hypertension; 2011 Apr; 57(4):846-51. PubMed ID: 21300663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis.
    Grassi G; D'Arrigo G; Pisano A; Bolignano D; Mallamaci F; Dell'Oro R; Quarti-Trevano F; Seravalle G; Mancia G; Zoccali C
    J Hypertens; 2019 Sep; 37(9):1746-1756. PubMed ID: 30950979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behaviour of regional adrenergic outflow in mild-to-moderate renal failure.
    Grassi G; Seravalle G; Arenare F; Buccianti G; Furiani S; Ilardo V; Bolla G; Mancia G
    J Hypertens; 2009 Mar; 27(3):562-6. PubMed ID: 19330916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension.
    Grassi G; Seravalle G; Turri C; Bolla G; Mancia G
    Hypertension; 2003 Mar; 41(3):558-62. PubMed ID: 12623959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.
    Leimbach WN; Wallin BG; Victor RG; Aylward PE; Sundlöf G; Mark AL
    Circulation; 1986 May; 73(5):913-9. PubMed ID: 3698236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias.
    Grassi G; Seravalle G; Dell'Oro R; Facchini A; Ilardo V; Mancia G
    J Hypertens; 2004 Sep; 22(9):1747-53. PubMed ID: 15311103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.